Skip to content
healthcare.dev

Guaifenesin

NDC 81033-102, Guaifenesin, liquid, from KESIN PHARMA CORPORATION.

Product NDC
81033-102
Status
Listed
Labeler
KESIN PHARMA CORPORATION
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81033-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN100 mg/5mL

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
81033-102-1681033010216473 mL in 1 BOTTLE (81033-102-16)
81033-102-518103301025150 CUP, UNIT-DOSE in 1 CARTON (81033-102-51) / 5 mL in 1 CUP, UNIT-DOSE (81033-102-05)
81033-102-528103301025250 CUP, UNIT-DOSE in 1 CARTON (81033-102-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-102-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 81033010216

    GET /v1/drugs/nadac/81033010216

Use it

Look up 81033-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81033-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81033-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.